Tele: 561.316.3330
Breaking Medical Device News

Wednesday, September 22, 2021

HomeProprioProprio Announces Research Collaboration with NYU Grossman School of Medicine

Proprio Announces Research Collaboration with NYU Grossman School of Medicine

January 21, 2021

Proprio notes that Dr. John Golfinos, the Joseph P. Ransohoff Professor and Chair of the Department of Neurosurgery, will serve as the Project Director.

Dr. Golfinos will help guide research and the development of the company’s breakthrough imaging and navigation system for neurosurgical and spinal applications.

Proprio is pleased to have one of the nation’s leading academic neurosurgery programs as a research collaborator,” said Gabriel Jones, Co-Founder and CEO of Proprio. “We believe leading programs like NYU Grossman School of Medicine can play a key role in the design of surgeon-centric products. Working with their Department of Neurosurgery will help us bring to market an imaging and navigation system that lets surgeons focus on the patient in an entirely new way.”

“Our department has long been a leader in advancing patient care through revolutionary technology and world-class surgical technique,” said Dr. Golfinos. “We’re excited about the Proprio system’s potential to greatly improve the accuracy and efficiency of complex surgeries.”

The company notes as part of the collaboration, NYU Grossman School of Medicine neurosurgery residents and research fellows will have the opportunity to work with the Proprio technology development team at Proprio’s Seattle headquarters, contributing to product requirements, testing versions of the Proprio system, providing surgical guidance on product development, and conducting clinical studies. Proprio intends to place units at NYU for in situ studies upon receiving FDA clearance.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

Kleiner Device Labs Receives FDA Market Clearance for KG2 Surge Flow-Thru Interbody System

The system maximizes total bone graft delivery volume, better distributes graft bilaterally into the intervertebral disc space, and streamlines the implant delivery, positioning, and grafting process for TLIF and PLIF spinal fusion procedures.

Matthew Cranfill New ExtriCARE USA Director Of Clinical Services

"Matt's impressive experience and skillset easily made him our top pick," said Peter Mason, President of ExtriCARE USA.

Shannon Lantzy MedCrypt New VP of Consulting

"I met Shannon at a healthcare-related event several years ago and was immediately impressed with her passion and drive to move healthcare into a digital future," said Mike Kijewski, CEO of MedCrypt.

Mark Foster Joins Xenocor BOD

Foster is a versatile and visionary C-Suite executive who brings 20 years of general management and leadership experience from both venture-backed growth-stage organizations and world-class medical device companies

Hinge Health Acquires the Most Advanced Computer Vision Technology for Tracking Human Motion

CEO Daniel Perez explained, “We won’t stop investing in technology to deliver the most patient-centered digital clinic that improves member experience and outcomes while reducing costs. wrnch allows us to take a giant leap forward in all respects.”

Dale W Wood Congratulates the Huma Team on Raising $130 Million

Major health and technology companies across the world have committed upwards of $130 million to Huma Therapeutics, the health-tech company backed by Dale Ventures.

Rhaeos Awarded $4 Million NIH SBIR Grant

Under the NIH SBIR grant, Rhaeos will leverage their existing wireless sensor hardware to provide additional quantitative flow data to the clinician, giving insight into this currently inaccessible and highly relevant shunt performance metric.

By using this website you agree to accept Medical Device News Magazine Privacy Policy